News Article featuring AskAt in YAKUJINIPPO on September 6, 2017, entitled “[AskAt] From Development in China to Worldwide Market Introduction, Expanding a Pain Therapeutic to Cancer”
This article highlights AskAt’s strategy of working on cancer and autoimmune disease indications with innovative partners in China and then quickly moving the results of these collaborations into global development.
Link to the article on YAKUJINIPPO homepage
